Obesity drugmaker BioAge targets $158 million in IPO

The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday.

Tomas Kauer Tomas Kauer
Sep 19, 2024 - 04:00
Obesity drugmaker BioAge targets $158 million in IPO
The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday. Read More
Read More